The Clinical Research Center (CRC) is a dynamic research unit operating within the structures of the Medical University of Białystok and the University Clinical Hospital. For over a decade, we have been a place where science meets clinical practice, with a mission to develop new methods to combat civilization diseases, such as diabetes, obesity, cardiovascular diseases, and cancer.
At the Clinical Research Center, we believe that every patient is unique and deserves personalized, precision-based care. Our primary goal is to advance precision medicine by identifying individual risk factors, understanding disease mechanisms, and tailoring therapies to meet the specific needs of each patient. We aim to make medicine more effective, personalized, and grounded in robust scientific evidence.
To achieve this, we utilize cutting-edge research methods, including:
- Genomics and Epigenomics – enabling the analysis of genetic predispositions and gene regulation,
- Metabolomics and Proteomics – providing insights into metabolic and protein processes at the molecular level,
- Advanced Bioinformatics Analyses – integrating data from diverse sources, including electronic health records, to identify new biomarkers and disease mechanisms.
Our research projects focus on testing innovative therapies, including the latest drugs used in the treatment of obesity and diabetes, as well as discovering biomarkers that can predict disease development, progression, and response to treatment. We also conduct studies on the impact of physical activity and diet on metabolic health, collaborating with sports organizations and international research institutions.
The CRC is an active participant in international research projects, collaborating with prestigious institutions such as Harvard Medical School and the University of Copenhagen. Through these partnerships, we seek innovative solutions for treating civilization diseases and gain access to the latest scientific and technological advancements, enabling the implementation of modern diagnostic and therapeutic methods.
Collaborations:
- Massachusetts General Hospital (link) - prof. Jose C. Florez, prof. Miriam Udler
- Broad Institute of MIT and Harvard (link) - prof. Josep Mercader
- Harvard Medical School - Prof. Jose C. Florez, prof. Miriam Udler
- Uniwersytet w Kopenhadze - prof. Steen Larsen
- German Diabetes Center - prof. Robert Wagner
- University of California, San Francisco - dr Mark Taylor
- University of California, Davis - West Coast Metabolomics Center - prof. Oliver Fiehn
Projects:
- GRADE
- MAGIC-T2D
- German Diabetes Study
- SUGAR-MGH
- SCRAMBLED EGGS
- PharmGENE
- All of US research program
- PRIMED consortium
- GLP-1 genetics consortium
